Starling Oncology, Inc. balance sheet STLNW

Annual Quarterly

As of Jun 30, 2026, Starling Oncology, Inc. had total assets of $178.2 million and total liabilities of $203.1 million. Total assets were up 11.5% from a year earlier. Stockholders' equity was negative, at -$24.9 million, because liabilities exceed assets. It held $41.1 million in cash and investments against $104.5 million of total debt, net debt of $63.4 million. The current ratio, current assets divided by current liabilities, was 1.36.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Assets
Cash
41
+35.7%
34
-32.4%
50
+48.3%
33
+139.0%
14
-87.8%
115
+1820.2%
6
Short-term investments
—
—
0
-100.0%
49
-17.4%
60
—
—
Long-term investments
—
—
—
0
-100.0%
58
—
—
Cash and investments
41
+35.7%
34
-32.4%
50
-40.1%
83
-37.3%
132
+14.7%
115
+1820.2%
6
Receivables
66
+19.2%
59
+22.1%
48
+14.1%
42
+6.4%
40
+99.0%
20
—
Inventory
20
+26.8%
17
+68.1%
10
-26.6%
14
+47.7%
9
+43.8%
6
—
Total current assets
129
+23.1%
113
+0.3%
112
-21.7%
143
+10.0%
130
-15.3%
154
+418.4%
30
Property and equipment, net
11
-2.5%
11
-10.1%
12
+9.2%
11
+27.3%
9
+103.9%
4
—
Goodwill
7
+0.0%
7
+0.0%
7
+0.0%
7
-66.2%
21
-19.6%
27
—
Total assets
178
+11.5%
165
-4.7%
173
-17.5%
209
-20.0%
262
+28.6%
203
+209.7%
66
Liabilities and equity
Accounts payable
60
+72.6%
43
+77.5%
24
+68.6%
14
+54.0%
9
-39.8%
16
—
Total current liabilities
95
+46.6%
71
+35.9%
52
+50.1%
35
+17.1%
30
-0.3%
30
+4.2%
29
Total liabilities
203
+20.4%
180
+6.7%
169
+11.1%
152
+9.9%
138
+39.5%
99
+164.1%
38
Stockholders' equity
-25
-177.3%
-16
-538.0%
4
-93.7%
57
-53.7%
123
+18.3%
104
+270.7%
28
Debt
Debt due within a year
—
—
—
—
—
0
—
Long-term debt
80
+6.5%
77
-16.9%
93
+7.3%
87
+7.7%
81
0
—
Lease liabilities
25
-12.6%
26
-12.5%
30
-8.7%
33
+18.7%
28
—
—
Total debt
105
+1.2%
104
-15.8%
123
+2.9%
120
+10.5%
108
+59145.9%
0
—
Net cash
-63
+13.0%
-70
+4.6%
-74
-99.1%
-37
-255.7%
24
-79.4%
115
—
Ratios
Current ratio
1.36x
1.59x
2.15x
4.12x
4.39x
5.17x
1.04x
Debt to equity
—
—
34.34x
2.10x
0.88x
0.00x
—
Return on equity
—
—
-1,801.70%
-145.67%
0.12%
-10.49%
-50.97%
Return on assets
-20.36%
-36.81%
-37.44%
-39.70%
0.06%
-5.37%
-21.80%
Book value per share
-0.25
-0.16
0.05
0.77
1.68
1.42
4.89
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cerritos, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1799191
Former names
Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)

Other Services-Offices & Clinics of Doctors of Medicine companies

All 12 Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.